# Gadavist

NDC: 50419-325
Generic name: gadobutrol
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20110314

FDA application: NDA201277

## Active ingredients

- GADOBUTROL: 604.72 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-325"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-325
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7afe34d-b70f-41a5-b89c-561bdf29f046